CATIE, Large Study on Schizophrenia, Released
CATIE (Clinical Antipsychotic Trials of Intervention Effectiveness) is the first large scale attempt to compare five different medications used to treat people living with schizophrenia. The study included both newer (atypical) and one older anti-psychotics. The study was funded by the National Institute of Mental Health (NIMH) and included 1400 subjects. The duration of the study was 18 months.
NAMI has made available several tools that can assist advocates in addressing concerns related to CATIE.
NAMI's statement on CATIE
Ten Questions on CATIE
CATIE Raises More Questions than It Answers
The CATIE Report as Published in the New England Journal of Medicine
NIMH Perspective on Antipsychotic Reimbursement: Using Results from CATIE
 | | | |
Join NAMI today!When you become a member of NAMI, you become part of America's largest grassroots organization dedicated to improving the lives of persons living with serious mental illness. And now you can join online. | 
